https://www.onclive.com/view/zanubrutinib-demonstrates-long-term-efficacy-safety-in-relapsed-refractory-cll-sll
Dec 7, 2025 - Zanubrutinib displayed long-term PFS and responses in patients with relapsed/refractory CLL/SLL.
long termzanubrutinibdemonstratesefficacysafety
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanubrutinib
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definitionzanubrutinibncidrugdictionary
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1015081/full
Relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) has poor clinical outcomes when treated with conventional salvage chemotherapy. Monotherapy ...
frontierszanubrutinibplussalvagechemotherapy